Volume 28, supplement 6, December 2021

ÉDITORIAL

Real life data for the treatment of hepatocellular carcinoma: What for? (p.4-6)
Sébastien Dharancy
Free Access

MINI-REVUES

Perspectives of association between immunotherapies and percutaneous ablation in hepatocellular carcinoma treatment (p.7-14)
Boris Guiu
Free Access

Therapeutic sequencing of second line systemic treatments for hepatocellular carcinoma – Real-life Data (p.15-25)
Xavier Adhoute, Rodolphe Anty
Free Access

Therapeutic perspectives of hepatocellular carcinoma in first line systemic setting following ESMO-ASIA 2021 (p.26-8)
Philippe Merle
Free Access

CAS CLINIQUES

Management and treatment of recurrent hepatocellular carcinoma after liver transplantation (p.29-32)
Guillaume Lassailly
Free Access

Intrahepatic multilocular hepatocellular carcinoma with macrovascular extension after failure of atezolizumab + bevacizumab (p.33-40)
Jean Marc Phelip, Amina Kherrour, Quentin Tournier, Nicolas Williet
Free Access